medicines: search

Press release: UK medicines investigators take part in international operation to tackle illegal Internet medicines

Press release: UK medicines investigators take part in international operation to tackle illegal Internet medicines

UK investigators in international operation to tackle illegal Internet medicines

LONDON -- The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has led an international operation, codenamed Pangea, in conjunction with INTERPOL and eight regulatory agencies worldwide to tackle the illegal sale and supply of medicines sold over the Internet.

Multi-national effort targets illegal online drugs

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has led an operation in conjunction with Interpol and medicines regulatory bodies to tackle illegal internet medicines.

Patent protection poses adverse impact on medicines

DOHA • Globalisation has exposed the developing nations to new challenges in the public health care. A World Health Organisation (WHO) expert said the strong and prolonged patent protection has an adverse impact on access to new essential medicines to the people of developing nations.

Patent protection poses adverse impact on medicines

DOHA • Globalisation has exposed the developing nations to new challenges in the public health care. A World Health Organisation (WHO) expert said the strong and prolonged patent protection has an adverse impact on access to new essential medicines to the people of developing nations.

Fake impotence drugs for online sale seized

A huge haul of fake medicines in a raid by Spanish police suggests that it's not a good idea to log on to buy pills to treat erectile dysfunction.

Healing through art

Awakes to new beginnings food, medicines, berries and flowers. The cycle begins and never ends, inside and out.�

Robotised dispensing system could cut medicine wastage

ROBOTISED systems could soon be dispensing medicines in hospital wards, thanks to a technology that by increasing the efficiency of dosage measurement also significantly reduces wastage.

Novartis Sips Up Nektar, and Its Inhalable (ie, Exubera) Intellectual Property

Novartis has strengthened its capabilities for developing medicines that can be delivered via the lungs through a definitive agreement to acquire the pulmonary drug delivery business unit of Nektar Therapeutics for USD 115 million in cash.

Fake impotence drugs for online sale seized

London, Nov 21 : A huge haul of fake medicines in a raid by Spanish police suggests that it's not a good idea to log on to buy pills to treat erectile dysfunction.

Interpol hits web drug sellers in nine countries

Authorities in nine countries have raided businesses suspected of supplying medicines illegally over the internet in an unprecedented global swoop coordinated by Interpol, officials said on Thursday.

Fungi scientists are endangered species

They give us our daily bread and beer, provide us with life-saving medicines and recycle our waste, yet the study of fungi – life forms that include everything from penicillin to truffles – could end within the next 10 years in Britain.

Google Flu: Internet disease tracker aims to save thousands from killer - Exclusive

The internet search giant aims to flag up disease blackspots by collating millions of searches for medicines by sufferers.

'India has to work on its patent laws'

AG has as many as 140 research projects, including new drug discovery and finding new uses for existing medicines, in various stages of clinical development.

Search Engines Must be Responsible for Information They Provide

One of China's top Internet search engines is responsible for causing the widespread of false information about medicines, Xinhua News Agency has recently reported.

Overseas patented drugs report may seek voluntary price control

NEW DELHI: The high-level government committee appointed by the ministry of chemicals & fertilisers for price negotiations of patented medicines is expected to go soft on multinational drug manufacturing companies holding patents.

Are pharmaceutical patents protected by human rights?

Millum J et al. - The International Bill of Rights enshrines a right to health, which includes a right to access essential medicines. This right frequently appears to conflict with the intellectual property regime that governs pharmaceutical patents. This article examines the recent attempt by the Committee on Economic, Social and Cultural Rights to resolve this issue and argues that it fails. This is problematic because it means defenders of the present patent regime can continue using human rights documents to support their position.

Interpol cracks down on illegal online meds

IN A FIRST OF ITS kind raid, Interpol coordinated a sting which saw police in nine different countries raid businesses thought to be selling medicines illegally online.

Scientists develop bacteria-propelled 'nanobot'

Canadian scientists have coupled live bacteria to microscopic beads to develop a self-propelling "nanobot," which could eventually be used to target tumors and deliver cancer-eliminating medicines. Report

Apotex loses patent challenge against Sanofi

OTTAWA -- The Supreme Court of Canada Thursday rejected a request from generic drug makers to prevent brand-name pharmaceutical companies from extending patents on components of previously patented medicines.

Nanotechnology Challenges FDA and Manufacturers

In the past three years, nanotechnology has gained prominence on the US Food and Drug Administration's regulatory and research agenda. The prospect that tiny materials may form effective, targeted medicines and improved versions of many FDA-regulated products has generated great enthusiasm among scientists and manufacturers. Some drugs that incorporate nanomaterials are already on the market, along with many over-the-counter sunscreens, cosmetics, dietary supplements, and food products.

Musculoskeletal center wins $2.2 million for drug safety

BIRMINGHAM, Ala. – The University of Alabama at Birmingham (UAB) Center for Education and Research on Therapeutics (CERTs) has won a $2.2 million federal grant to study the risks and benefits of a newer class of medicines called biologics. These are genetically engineered therapies that target the immune system of patients who have rheumatoid arthritis, Crohn's disease, psoriasis and other autoimmune disorders.

Europe's Competition DG slams big pharma and calls for the Community patent

In what must count as one of the least surprising pieces of news ever to have come out of Brussels, the European Commission’s Competition DG has announced that its preliminary findings in an on-going investigation of the pharmaceutical industry are that big pharmaceutical companies are very bad. They game the patent system, prevent generics from entering markets and make medicines much more expensive than they could be.

Oxford Genome Sciences Changes its Name to Oxford BioTherapeutics

Oxford, UK, 1 December 2008. Oxford Genome Sciences announced today that it has changed its name to Oxford BioTherapeutics (OBT). The new name will take effect immediately and comes at an exciting time in the Company’s development as it continues to advance its pipeline of promising novel antibody-based cancer therapeutics. The name reflects the company’s complete focus on the discovery and development of targeted antibody medicines to address large and unmet patient needs in the field of oncology.

Search took 0.02 seconds.